Hiraku Nakagawa

Title: Hiraku Nakagawa: Innovator in Monoclonal Antibody Development

Introduction

Hiraku Nakagawa is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work has implications for various applications in medical research and diagnostics.

Latest Patents

Hiraku Nakagawa holds a patent for an anti-human MP52 monoclonal antibody. This innovative mouse anti-human MP52 monoclonal antibody specifically binds to dimeric human MP52 but not to monomeric human MP52. The antibody, which comprises IgG and exhibits high specificity, is produced by sensitizing mice with human MP52 generated in CHO cells. This antibody is particularly useful for purifying or assaying human MP52 produced by genetic engineering techniques. He has 1 patent to his name.

Career Highlights

Hiraku Nakagawa is associated with Hoechst Marion Roussel, where he has contributed to various research initiatives. His work has been instrumental in advancing the understanding and application of monoclonal antibodies in therapeutic contexts.

Collaborations

Hiraku Nakagawa has collaborated with notable colleagues, including Hiroshi Kitagawa and Tomofumi Jitsukawa. These collaborations have fostered innovation and enhanced the research output in their respective fields.

Conclusion

Hiraku Nakagawa's contributions to the field of monoclonal antibodies exemplify the impact of innovative research in biotechnology. His work continues to influence advancements in medical diagnostics and therapeutic applications.